Tosk, Inc.
20Patents
15Active
20Granted
46Portfolio score
Filing activity: Dec 27, 1999 → Sep 24, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6291243A | P element derived vector and methods for its use | Chemistry; Metallurgy | 139 | Expired |
| US6475798B2 | P element derived vector and methods for its use | Chemistry; Metallurgy | 30 | Expired |
| US7998967B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 7 | Active |
| US6365129B1 | Invivo high throughput toxicology screening method | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8853227B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 6 | Active |
| US6855504B2 | In vivo high throughput toxicology screening method | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9061038B2 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Human Necessities | 5 | Active |
| US6316690A | Non-mammalian transgenic animal model for cellular proliferative diseases | Human Necessities | 4 | Expired |
| US9382287B2 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Human Necessities | 3 | Active |
| USRE48253E1 | Methotrexate adjuvants to reduce toxicity and methods for using the same | General | 3 | Active |
| US11446303B2 | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions | Human Necessities | 1 | Active |
| US11390626B2 | Pyrazolopyrimidine modulators of RAS GTPase | Human Necessities | 0 | Active |
| US12109222B2 | Methods and compositions for treating mucositis | Human Necessities | 0 | Active |
| US9468613B2 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Human Necessities | 0 | Active |
| US8227517B2 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Human Necessities | 0 | Active |
| US12419893B2 | Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine | Human Necessities | 0 | Active |
| US12194043B2 | Uridine phosphorylase inhibitors to treat or prevent pulmonary disease | Human Necessities | 0 | Active |
| US10660318B2 | Non-mammalian RAS transgenic animal model | Human Necessities | 0 | Active |
| US12180220B2 | Heteroaryl modulators of RAS GTPase | Chemistry; Metallurgy | 0 | Active |
| US11945803B2 | Modulators of RAS GTPase | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.